Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies

被引：1

作者：

Upadhayaya, Ram S. ^{[1
]}

Kethiri, Raghava Reddy ^{[1
]}

Vellanki, Avanish ^{[2
]}

Lightfoot, Jeff ^{[3
]}

Local, Andrea ^{[4
]}

Rice, William G. ^{[4
]}

机构：

[1] Laxai Avanti Life Sci, Hyderabad, Andhra Pradesh, India

[2] Aptose Biosci Inc, Redwood City, CA USA

[3] Aptose Biosci Inc, Mississauga, ON, Canada

[4] Aptose Biosci Inc, San Diego, CA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.5212.5212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5212

引用

页数：4

共 50 条

[21] Discovery of the natural product 3′,4′,7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor
Li, Jiao
Zou, Wei
Yu, Koukou
Liu, Bing
Liang, Weifeng
Wang, Lisha
Lu, Yin
Jiang, Zequn
Wang, Aiyun
Zhu, Jiapeng
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 903 - 913
[22] Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors
Qiao, Xue-Peng
Wang, Xue-Ting
Wang, Shuai
Mu, Hong-Xia
Wang, Qing-Shan
Ab, Shi-Wu Chen
BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 106
[23] Discovery and preclinical development of selective JAK inhibitors for the treatment of hematological malignancies
Fridman, S.
Li, J.
Liu, P.
Caulder, E.
Crowgey, E.
Favata, M.
Guoen, G.
Li, Y.
Covington, M.
Rodgers, J.
Combs, A.
Yeleswaram, S.
Newton, R.
Scherle, P.
Vaddi, K.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 117 - 117
[24] Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
Watts, Ellen
Heidenreich, David
Tucker, Elizabeth
Raab, Monika
Strebhardt, Klaus
Chesler, Louis
Knapp, Stefan
Bellenie, Benjamin
Hoelder, Swen
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (05) : 2618 - 2637
[25] Tumor-selective, chaperone-mediated protein degradation (CHAMP) of the bromodomain transcription factor BRD4
Foley, K.
Dai, Y.
Ding, Q.
Du, F.
Li, J.
Lv, C.
Prince, T.
Sun, Y.
Wang, M.
Wang, R.
Yang, X.
Wang, Y.
Wang, Z.
Ma, L.
Ye, L. Y. Long
Yin, W. Y. Wei
Ying, C. Y. Chenghao
Yu, M. Y. Min
Zhu, Y.
Ying, W.
EUROPEAN JOURNAL OF CANCER, 2022, 174 : S27 - S27
[26] TARGETING OF BRD4 AS A NOVEL THERAPEUTIC CONCEPT IN JAK2 V617F+MPN
Keller, A.
Peter, B.
Zuber, J.
Berger, D.
Staber, P. B.
Bettelheim, P.
Valent, P.
Hadzijusufovic, E.
HAEMATOLOGICA, 2016, 101 : 89 - 89
[27] Evaluation of BRD4 as potential target in JAK2 V617F+MPN cells
Keller, A.
Peter, B.
Zuber, J.
Valent, P.
Hadzijusufovic, E.
Oncology Research and Treatment, 2015, 38 : 226 - 227
[28] Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease
Yang, Yueyue
Liu, Hongli
Yuan, Haoxing
Lyu, Kaikai
Zhong, Haiyang
Li, Yanlian
Cao, Danyan
Zhao, Wenchao
Zhang, Haoran
Xiong, Bing
Chen, Danqi
Guo, Dong
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (05) : 5257 - 5274
[29] Targeting STAT5 in Hematologic Malignancies through Inhibition of the Bromodomain and Extra-Terminal (BET) Bromodomain Protein BRD2
Liu, Suhu
Walker, Sarah R.
Nelson, Erik A.
Cerulli, Robert
Xiang, Michael
Toniolo, Patricia A.
Qi, Jun
Stone, Richard M.
Wadleigh, Martha
Bradner, James E.
Frank, David A.
MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1194 - 1205
[30] Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay
Chen, Zhifeng
Zhang, Hao
Liu, Shien
Xie, Yiqian
Jiang, Hao
Lu, Wenchao
Xu, Heng
Yue, Liyan
Zhang, Yuanyuan
Ding, Hong
Zheng, Mingyue
Yu, Kunqian
Chen, Kaixian
Jiang, Hualiang
Luo, Cheng
MEDCHEMCOMM, 2017, 8 (06) : 1322 - 1331

← 1 2 3 4 5 →